170 related articles for article (PubMed ID: 9864601)
1. [Prevention of heart failure].
Logeart D; Guiti C; Ennezat PV; Cohen-Solal A
Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1333-41. PubMed ID: 9864601
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic and clinical rationales for using beta-blockers in heart failure.
Bristow MR
J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
[TBL] [Abstract][Full Text] [Related]
3. Preventing congestive heart failure.
Cohn JN
Am Fam Physician; 1998 Apr; 57(8):1901-4. PubMed ID: 9575327
[TBL] [Abstract][Full Text] [Related]
4. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
Sander GE; McKinnie JJ; Greenberg SS; Giles TD
Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
[TBL] [Abstract][Full Text] [Related]
6. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
7. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
Udelson JE; Konstam MA
J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
[TBL] [Abstract][Full Text] [Related]
8. [Ischemic heart failure].
Inoue K; Hori M
Nihon Rinsho; 2003 May; 61(5):862-6. PubMed ID: 12755016
[TBL] [Abstract][Full Text] [Related]
9. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
Greenberg BH
J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
[TBL] [Abstract][Full Text] [Related]
12. New concepts in post-infarction ventricular remodeling.
Udelson JE; Patten RD; Konstam MA
Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
[TBL] [Abstract][Full Text] [Related]
13. Drugs for left ventricular remodeling in heart failure.
Frigerio M; Roubina E
Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
[TBL] [Abstract][Full Text] [Related]
14. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
15. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
van Veldhuisen DJ
Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure.
Izzo JL; Gradman AH
Med Clin North Am; 2004 Sep; 88(5):1257-71. PubMed ID: 15331316
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
20. [Chronic heart failure--the epidemic of the 21st century].
Czuriga I
Orv Hetil; 2005 May; 146(20 Suppl 2):1075-87. PubMed ID: 15945236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
